News Briefs

News Briefs

✦ The FDA approved an additional indication for Jardiance (empagliflozin), allowing the drug to be used to “reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart fai...
0 Comments
© 2024 MMIT

News Briefs

✦ UnitedHealth Group will acquire fellow Minnesota-based health plan PreferredOne from University of Minnesota-affiliated provider Fairview Health Services, according to the Minneapolis Star-Tribune. UnitedHea...
0 Comments
© 2024 MMIT

News Briefs

✦ Centene Corp. on Aug. 17 said the Ohio Dept. of Medicaid (ODM) made the long-awaited decision to renew its managed Medicaid contract with subsidiary Buckeye Health Plan. ODM in April named six other managed care...
0 Comments
© 2024 MMIT

News Briefs

✦ The U.S. Court of Appeals for the District of Columbia Circuit on Aug. 13 overturned a key court victory notched by UnitedHealthcare regarding Medicare Advantage overpayments. In 2018, a lower federal court side...
0 Comments
© 2024 MMIT

News Briefs

✦ The HHS Office of Inspector General on Aug. 4 revealed that it will investigate the how the FDA implements its accelerated approval pathway in the wake of the agency approving the controversial Alzheimer’s dru...
0 Comments
© 2024 MMIT

News Briefs

✦ The Dept. of Justice’s antitrust division is considering whether to file a suit aiming to block UnitedHealth Group’s $8 billion proposed acquisition of Change Healthcare, according to press reports. The Bide...
0 Comments
© 2024 MMIT

News Briefs

✦ The U.S. Dept. of Justice has intervened in six False Claims Act complaints accusing Kaiser Permanente of submitting inaccurate diagnosis codes to receive inflated Medicare Advantage reimbursements. According to...
0 Comments
© 2024 MMIT

News Briefs

✦ Bristol Myers Squibb will voluntarily withdraw the U.S. indication for Opdivo (nivolumab) as a monotherapy for people with hepatocellular carcinoma who previously were treated with sorafenib. The move follows an...
0 Comments
© 2024 MMIT

News Briefs

✦ The bipartisan infrastructure package that U.S. senators are currently negotiating will further delay a never-implemented regulation that would restructure the Medicare Part D drug rebate system, various news ou...
0 Comments
© 2024 MMIT

News Briefs

✦ HHS Secretary Xavier Becerra renewed the COVID-19 public health emergency (PHE) for an additional 90 days on July 19. The decision was something of a formality, as statements by Biden administration officials ha...
0 Comments
© 2024 MMIT